IMIDomics Strengthens its Leadership with the Addition of Dr. Eric Perakslis to its Executive Team and Dr. Ramon Felciano to its Advisory Team

SAN RAFAEL, Calif.–(BUSINESS WIRE)–IMIDomics, a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases (IMIDs), proudly announces the addition of Dr. Eric Perakslis, a highly accomplished pharmaceutical R&D and digital sciences executive, as Senior Vice President and Chief Technology Officer (CTO). In addition, Dr. Ramon Felciano, joins as…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks